Mts wrote:
"For the 9 week trial in Finland... Well, the Finnish gov't was only able to afford enough Herceptin for 9 weeks... and so it went. "
This is more or less rubbish. Naturally 9 weeks treatment is less expensive than one year, but the main fact is that we are looking for the optimal treatment of bc. New trial is going on, please visit:
http://www.druglib.com/trial/97/NCT00593697.html
Besides, the normal duration of taxane treatment is nine weeks in Finland. The point of FinHer study was, should we start Herceptin with Docetaxel or Vinorelbine. The decision to continue with Herceptin is always available. The vast majority of finnish HER2 patients are comfortable and safe with 9 weeks of Herceptin.